Company profile

LiVET AG

We develop and produce rapid molecular point-of-care diagnostic tests for veterinary use. Based on our proprietary platform technology, veterinarians are able to diagnose infectious disease on-site and within only 30 minutes for up to 16 samples at once. This allows for immediate and specific treatment. Our first multiplex panel test for respiratory diseases in horses will be available by summer 2020. We aim to change the way of thinking about diagnostics in the veterinary market, implementing point-of-care testing as the new standard. By bringing the application of specialized laboratories closer to the patients we strive to increase the quality of animal health care.

More news about LiVET AG

15.07.2022 09:00

Ender diagnostics und livet rücken näher zusammen

Please login or
register to use the
awards follow feature
24.04.2020 09:47

1,3 Millionen Franken Risikokapital für LiVET

Please login or
register to use the
awards follow feature
LiVET AG

Founded
2019

Kanton
BE

Homepage

rss